[68Ga]Ga-PentixaFor (CXCR4) PET/MR for Initial Staging and Follow up in Multiple Myeloma: Prospective Comparison With Standard of Care PET/CT and Evaluation of Therapy Influence
Latest Information Update: 01 Jul 2025
At a glance
- Drugs 68Ga PentixaFor (Primary)
- Indications Multiple myeloma
- Focus Diagnostic use
Most Recent Events
- 25 Jun 2025 Status changed from not yet recruiting to recruiting.
- 18 Mar 2025 New trial record